Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature
- PMID: 29754705
- DOI: 10.1016/j.rcp.2017.01.004
Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature
Abstract
Background: Previous studies suggest that inflammatory molecules play an important role in the pathophysiology of Bipolar Disorder (BD). The evidence suggests that BD may present a progressive course. Therefore there are theories that postulate the relationship between progression and stages of the disease with distinct peripheral biomarkers.
Objective: The aim of this study was to carry out a systematic review of the literature of studies about the association between peripheral inflammatory markers and clinical variables related with staging in BD patients.
Methods: We conducted a systematic review using electronic databases: PubMed, SciELO, LiLACS and PsycINFO. Keywords were divided into inflammatory markers and, BD and staging. Studies involving euthymic BD patients, studies evaluating peripheral biomarkers and studies correlating these with clinical variables related to neuroprogression or stage of BD were included.
Results: We present and discuss the methods and findings of ten articles. The inflammatory markers were measured with different techniques and show some contradictories results. The TNF superfamily and inflammatory cytokines may have a relationship with the neuroprogression of the disease.
Conclusions: This study suggests that TNF and ILs could play a role in neuroprogression. However, longitudinal studies are needed to clarify the relationship between factors associated with neuroprogression.
Keywords: Biomarcadores inflamatorios; Bipolar disorders; Estadificación de la enfermedad; Inflammatory biomarkers; Revisión sistemática; Staging illness; Systematic review; Trastorno bipolar.
Copyright © 2017 Asociación Colombiana de Psiquiatría. Publicado por Elsevier España. All rights reserved.
Similar articles
-
A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients.J Psychiatr Res. 2017 Sep;92:160-182. doi: 10.1016/j.jpsychires.2017.03.018. Epub 2017 Mar 29. J Psychiatr Res. 2017. PMID: 28458141
-
Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review.Aust N Z J Psychiatry. 2023 Mar;57(3):328-343. doi: 10.1177/00048674221091731. Epub 2022 Apr 11. Aust N Z J Psychiatry. 2023. PMID: 35403455 Free PMC article.
-
Biomarkers and staging of bipolar disorder: a systematic review.Trends Psychiatry Psychother. 2015 Jan-Mar;37(1):3-11. doi: 10.1590/2237-6089-2014-0002. Epub 2014 Dec 9. Trends Psychiatry Psychother. 2015. PMID: 25860561
-
Staging and neuroprogression in bipolar disorder: a systematic review of the literature.Braz J Psychiatry. 2013 Mar;35(1):70-4. doi: 10.1016/j.rbp.2012.09.001. Braz J Psychiatry. 2013. PMID: 23567604
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
Correlations between peripheral levels of inflammatory mediators and frontolimbic structures in bipolar disorder: an exploratory analysis.CNS Spectr. 2022 Oct;27(5):639-644. doi: 10.1017/S1092852921000596. Epub 2021 Jun 14. CNS Spectr. 2022. PMID: 34121653 Free PMC article.
-
Inflammation Markers in Patients with Bipolar Disorder Who Have Committed Offenses and Their Relationship with Criminal Behavior.Medicina (Kaunas). 2023 Sep 27;59(10):1725. doi: 10.3390/medicina59101725. Medicina (Kaunas). 2023. PMID: 37893443 Free PMC article.
-
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.Heliyon. 2020 May 20;6(5):e03990. doi: 10.1016/j.heliyon.2020.e03990. eCollection 2020 May. Heliyon. 2020. PMID: 32462093 Free PMC article. Review.
-
Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia versus healthy controls: a prospective 'true-to-life' study.Ther Adv Psychopharmacol. 2023 Feb 16;13:20451253221135463. doi: 10.1177/20451253221135463. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 36814596 Free PMC article.
-
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review.Ther Adv Psychopharmacol. 2024 Feb 6;14:20451253241227772. doi: 10.1177/20451253241227772. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38322010 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical